---
title: | patient-derived models
description: patient-derived models |
---

[![HUB Organoids](https://blog.huborganoids.nl/hubfs/raw_assets/public/HUBOrganoids_May2021/images/logo-huborganoids-white.svg "HUB Organoids")](https://huborganoids.nl/)

![merk-m-logo-blue](https://blog.huborganoids.nl/hs-fs/hubfs/merk-m-logo-blue.png?width=728&height=225&name=merk-m-logo-blue.png)

- [services](https://huborganoids.nl/services) 
    - [services overview](https://www.huborganoids.nl/services-overview/)
    - [drug screening](https://www.huborganoids.nl/services/hub-drug-screening/)
    - [model and assay development](https://www.huborganoids.nl/services/)
    - [clinical trials in a dish](https://www.huborganoids.nl/hub-organoid-clinical-trial-in-a-dish/)
- [Technology](https://huborganoids.nl/hub-technology)
- [Company](https://huborganoids.nl/about) 
    - [about us](https://huborganoids.nl/about)
    - [Careers](https://huborganoids.nl/careers)
    - [events](https://www.huborganoids.nl/meet-us/)
    - [latest news](https://www.huborganoids.nl/news-insights-2/)
- [Resources](https://huborganoids.nl/resources/)
- [Blog](https://blog.huborganoids.nl)
- [license program](https://www.huborganoids.nl/licenses/)
- [Contact](https://resources.huborganoids.nl/contact-hub)

[discover organoid services](https://www.huborganoids.nl/services-overview/)

- [services](https://huborganoids.nl/services) 
    - [services overview](https://www.huborganoids.nl/services-overview/)
    - [drug screening](https://www.huborganoids.nl/services/hub-drug-screening/)
    - [model and assay development](https://www.huborganoids.nl/services/)
    - [clinical trials in a dish](https://www.huborganoids.nl/hub-organoid-clinical-trial-in-a-dish/)
- [Technology](https://huborganoids.nl/hub-technology)
- [Company](https://huborganoids.nl/about) 
    - [about us](https://huborganoids.nl/about)
    - [Careers](https://huborganoids.nl/careers)
    - [events](https://www.huborganoids.nl/meet-us/)
    - [latest news](https://www.huborganoids.nl/news-insights-2/)
- [Resources](https://huborganoids.nl/resources/)
- [Blog](https://blog.huborganoids.nl)
- [license program](https://www.huborganoids.nl/licenses/)
- [Contact](https://resources.huborganoids.nl/contact-hub)

# HUB's blog

![Ask the experts - organoids as model systems](https://blog.huborganoids.nl/hubfs/Copy%20of%20HUB%20News%20(22).png)

### [Ask the experts - organoids as model systems](https://blog.huborganoids.nl/ask-the-experts-organoids-as-model-systems)

Published by Federica Parisi, PhD on Oct 14, 2021

In this last episode of our "Ask the experts" series we explore the difference between HUB Organoids™ and iPSCs-derived organoids and discuss optimal applications of organoids compared to other preclinical models such as 2D cell lines and animal models.

[read more](https://blog.huborganoids.nl/ask-the-experts-organoids-as-model-systems)

![HUB Organoids](https://blog.huborganoids.nl/hubfs/raw_assets/public/HUBOrganoids_May2021/images/logo-huborganoids-white.svg "HUB Organoids")

[Privacy Policy](https://huborganoids.nl/privacy-policy)

<https://www.linkedin.com/company/huborganoids/>

HUB Organoids is now part of the Life Science Business of Merck KGaA, Darmstadt, Germany

***FOR RESEARCH USE ONLY.**  Unless otherwise stated in our catalog or other company documentation  
 accompanying the product(s), our products are intended for research use only and are not to be used   
 for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro   
 diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to   
humans or animals.*